advertisement

HIV/AIDS

14 December 2010

R4.3 billion ARV tender for pharmaceutical companies

An ARV tender worth R4.3 billion over two years has been awarded to 10 pharmaceutical companies, Health Minister Aaron Motsoaledi announced.

An antiretroviral (ARV) tender worth R4.3 billion over two years has been awarded to 10 pharmaceutical companies, Health Minister Aaron Motsoaledi announced.

The new tender starts in January 2011 and runs for two years.

More competition = better prices

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.